UK Moves to Make Whole Genome Sequencing Standard in the NHS, Improving Diagnosis for Rare Disease Patients

A recent study has demonstrated that through standardizing the whole genome sequencing process and making it routine for patients, we can improve rare disease diagnosis across the board. Earlier diagnosis…

Continue Reading UK Moves to Make Whole Genome Sequencing Standard in the NHS, Improving Diagnosis for Rare Disease Patients

The World’s Largest Genetic Study of Chronic Fatigue Syndrome is About to be Launched

According to a recent article in The Guardian, funding received from the NIHR and Medical Research Council will facilitate the launch of the largest genetic study of chronic fatigue syndrome…

Continue Reading The World’s Largest Genetic Study of Chronic Fatigue Syndrome is About to be Launched

First Two Patients Treated with AMT-130 for Huntington’s Disease Trial

uniQure has recently began their Phase I/II clinical trial of AMT-130, a gene therapy for the treatment of Huntington's disease. Two patients are included so far, with one being given…

Continue Reading First Two Patients Treated with AMT-130 for Huntington’s Disease Trial

Scientists Find New Pathway Leading to Less Inflammation in Asthma and Other Allergic Diseases

Why are most people able to tolerate cat’s hair while some people have severe reactions to the ubiquitous and practically invisible dust mites? A recent SciTech Daily article followed La…

Continue Reading Scientists Find New Pathway Leading to Less Inflammation in Asthma and Other Allergic Diseases
Psoriasis Drug Now a Potential Candidate to Treat PsA and Uveitis
Hans / Pixabay

Psoriasis Drug Now a Potential Candidate to Treat PsA and Uveitis

  According to LabioTech, a psoriasis drug developed by biotechnology company Affibody showed promising results in a Phase II clinical trial (AFFIRM-35). This trial, which consisted of 108 participants with…

Continue Reading Psoriasis Drug Now a Potential Candidate to Treat PsA and Uveitis
ANCA Vasculitis Patients at an Increased Risk of Depression, Study Finds
source: pixabay.com

ANCA Vasculitis Patients at an Increased Risk of Depression, Study Finds

According to a story from ANCA Vasculitis News, a recent review study has determined that patients living with ANCA vasculitis and other related diseases are at a higher than average…

Continue Reading ANCA Vasculitis Patients at an Increased Risk of Depression, Study Finds
NAFLD and NASH Predicted to Be a Growing Health Emergency
https://pixabay.com/en/doctor-hospital-bed-delivery-labor-840127/

NAFLD and NASH Predicted to Be a Growing Health Emergency

  In a Business Wire press release, the Canadian NASH Network (CanNASH) shared the results of a recent study predicting a severe increase in cases of nonalcoholic fatty liver disease…

Continue Reading NAFLD and NASH Predicted to Be a Growing Health Emergency
International Panel Gives Expert Advice on the Management of COVID-19 and Blood Cancers
source: pixabay.com

International Panel Gives Expert Advice on the Management of COVID-19 and Blood Cancers

  COVID-19 has now taken hold in over one hundred eighty countries. According to a recent article in The Lancet, in May of 2020, the United States reported the highest…

Continue Reading International Panel Gives Expert Advice on the Management of COVID-19 and Blood Cancers
Early Success in Trials for Experimental Gene Therapies for Fabry Disease and Cystinosis
source: pixabay.com

Early Success in Trials for Experimental Gene Therapies for Fabry Disease and Cystinosis

As reported in Business Fortnight, the top level gene therapy company AVROBIO has announced successful clinical trials for investigational drugs for Fabry disease and cystinosis. The CEO of AVROBIO, Geoff…

Continue Reading Early Success in Trials for Experimental Gene Therapies for Fabry Disease and Cystinosis
An Experimental Treatment for Primary Hyperoxaluria has Earned Rare Pediatric Disease Designation
source: pixabay.com

An Experimental Treatment for Primary Hyperoxaluria has Earned Rare Pediatric Disease Designation

According to a story from BioSpace, the biopharmaceutical company Dicerna Therapeutics, Inc. has announced recently that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to…

Continue Reading An Experimental Treatment for Primary Hyperoxaluria has Earned Rare Pediatric Disease Designation
Dr. Eunice Wang Discusses Newly Approved Treatments for Acute Myeloid Leukemia
source: pixabay.com

Dr. Eunice Wang Discusses Newly Approved Treatments for Acute Myeloid Leukemia

  Earlier this year, The Leukemia & Lymphoma Society hosted a presentation by Dr. Eunice Wang, Clinical Leukemia Service, Professor of Oncology, Roswell Park Comprehensive Cancer Center. Dr. Wang’s presentation…

Continue Reading Dr. Eunice Wang Discusses Newly Approved Treatments for Acute Myeloid Leukemia
Close Menu